Depression is widely reported to be more common in women than in men, with women twice as likely to receive a diagnosis than men. A new sex-specific study from McGill University has found that there are differences between male and female genes and how they relate to depression.
New research from Boston Medical Center and Boston University School of Public Health found that municipalities with high numbers of opioid-related emergencies that introduced post-overdose programs were associated with lower opioid related death rates over time when compared to those that did not implement these programs. Published in JAMA Psychiatry, the study showed that implementation of these outreach programs was also associated with a significant and gradual reduction of opioid emergency response rates.
The Acute Hospital Rehabilitation Intensive Service (ARISE) program, developed in 2020 by the Johns Hopkins Department of Physical Medicine and Rehabilitation (PM&R), may increase the chances of patients hospitalized with COVID-19 getting discharged to their home rather than to a rehabilitation facility that provides post-hospitalization care services.
Just an hour less sleep a night affects what and how children eat, University of Otago research shows.
People living in the United States must travel significantly farther to access methadone treatment for opioid addiction than Canadians, suggests a new study led by Washington State University researchers.
Many types of arthritis can affect your musculoskeletal system. Joints are physical points of connection between two bones, and cartilage is the tissue that covers the surface of the bone at the joint. A membrane, called the synovial membrane, lines the joint and is filled with fluid known as synovial fluid. All these components work together to make movement easy.
Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener, sucralose, lowers activation of T-cells, an important component of the immune system, in mice.
Scientists have long known that mitochondria play a crucial role in the metabolism and energy production of cancer cells. However, until now, little was known about the relationship between the structural organization of mitochondrial networks and their functional bioenergetic activity at the level of whole tumors.
A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators at Dana-Farber Cancer Institute and other research centers report in a new pair of studies in the journal Nature.
Researchers from The University of Texas MD Anderson Cancer Center showed that inhibiting menin with revumenib, previously known as SNDX-5613, yielded encouraging responses for advanced acute leukemias with KMT2A rearrangements or mutant NPM1. Findings from the Phase I AUGMENT-101 trial were published today in Nature.